We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
High-density lipoprotein cholesterol: an emerging target for stroke treatment.
Stroke; a Journal of Cerebral Circulation 2007 March
BACKGROUND AND PURPOSE: This review characterizes the current state of knowledge of high-density lipoprotein (HDL) in relation to stroke.
SUMMARY OF REVIEW: HDL has anti-atherosclerotic and anti-inflammatory properties and is an important component in atherosclerosis. Serum HDL-cholesterol levels are inversely related to heart disease and stroke risk. There are various established and experimental treatments which can raise serum HDL cholesterol and improve its function.
CONCLUSIONS: HDL is an emerging target for atherosclerotic stroke treatment with the potential to dramatically impact the care of stroke patients.
SUMMARY OF REVIEW: HDL has anti-atherosclerotic and anti-inflammatory properties and is an important component in atherosclerosis. Serum HDL-cholesterol levels are inversely related to heart disease and stroke risk. There are various established and experimental treatments which can raise serum HDL cholesterol and improve its function.
CONCLUSIONS: HDL is an emerging target for atherosclerotic stroke treatment with the potential to dramatically impact the care of stroke patients.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app